Universitätsklinikum Bonn

Hospital


Location: Bonn, Germany (DE) DE

ISNI: 000000008786803X

ROR: https://ror.org/01xnwqx93

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial (2016) Gluz O, Liedtke C, Huober J, Peyro-Saint-Paul H, Kates RE, Kreipe HH, Hartmann A, et al. Journal article German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging (2016) Barthel H, Meyer PT, Drzezga A, Bartenstein P, Boecker H, Brust P, Buchert R, et al. Journal article Mutant desmin substantially perturbs mitochondrial morphology, function and maintenance in skeletal muscle tissue (2016) Winter L, Wittig I, Peeva V, Eggers B, Heidler J, Chevessier F, Kley RA, et al. Journal article Nicht-invasive Beatmung als Therapie der akuten respiratorischen Insuffizienz (2015) Westhoff M, Schönhofer B, Neumann P, Bickenbach J, Barchfeld T, Becker H, Dubb R, et al. Journal article, Review article CB2 receptor-mediated effects of pro-inflammatory macrophages influence survival of cardiomyocytes (2015) Heinemann JC, Duerr GD, Keppel K, Breitbach M, Fleischmann BK, Zimmer A, Wehner S, et al. Journal article Impaired border zone formation and adverse remodeling after reperfused myocardial infarction in cannabinoid CB2 receptor deficient mice (2015) Duerr GD, Heinemann JC, Gestrich C, Heuft T, Klaas T, Keppel K, Roell W, et al. Journal article Endocannabinoids in adaptation to injury: Ready to move from bench to bedside? (2015) Dewald O, Zimmer A Journal article MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive Glioblastoma: The DIRECTOR Trial (2015) Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, et al. Journal article The toxic effect of R350P mutant desmin in striated muscle of man and mouse. (2015) Clemen C, Stöckigt F, Strucksberg KH, Chevessier F, Winter L, Schütz J, Bauer R, et al. Journal article, Original article A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma (2015) Westphal M, Heese O, Steinbach JP, Schnell O, Schackert G, Mehdorn M, Schulz D, et al. Journal article